Not specifically. Though both goal GLP-one receptors, Tirz also activates GIP receptors, making it a twin agonist. This broader system is considered to improve its consequences on insulin sensitivity and hunger signaling in study products. El reto farmacológico de esta clase de moléculas es el harmony entre las tres actividades: https://peptisell.com/product/tirzepatide-pen